Roche’s RoACTEMRA monotherapy showed superior improvement in rheumatoid arthritis
2 March 2012 | By Roche
Roche announced preliminary results from the ADACTA study...
List view / Grid view
News
Sanofi appoints Jean-Luc Lowinski, Senior Vice President, Asia Region
2 March 2012 | By Sanofi
Sanofi is pleased to announce the appointment of Jean-Luc Lowinski, as Senior Vice President, Asia Region, effective 1st May...
Amgen announces initial results of tender offer for outstanding shares of Micromet, Inc.
2 March 2012 | By Amgen
Tender offer to acquire all outstanding shares of Micromet, Inc. - satisfied...
FDA approves first four-strain flu vaccine
1 March 2012 | By AstraZeneca
MedImmune, has received approval from the US FDA for FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) in the prevention of influenza...
GSK and Daiichi Sankyo vaccines joint venture to become largest vaccines company in Japan
1 March 2012 | By GlaxoSmithKline
GSK has signed an agreement with Daiichi Sankyo Co., Ltd. to form a Joint Venture...
Abbott to build nutrition manufacturing facility in Ohio
1 March 2012 | By Abbott
Plant to employ 240 to meet fast-growing demand for adult nutrition products...
AstraZeneca announces Non-Executive changes, retirement of Chairman and appointment of successor
1 March 2012 | By AstraZeneca
Leif Johansson proposed to shareholders for election as a Non-Executive Director...
Genzyme begins shipping Fabrazyme from newly approved Framingham manufacturing plant
1 March 2012 | By Sanofi
Genzyme has begun shipping Fabrazyme® (agalsidase beta)...
Mergers and acquisitions
29 February 2012 | By Helen Difford, Editor of European Pharmaceutical Review
Helen Difford, Editor of European Pharmaceutical Review, looks at the reasons behind recent mergers and acquisitions within the pharmaceutical sector...
Boehringer Ingelheim expands capabilities
29 February 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has expanded its biopharmaceutical development & manufacturing capabilities...
Intelligently dose chemical reactors at high flow rates with the Atlas Syringe Pump
29 February 2012 | By kdm communications limited
Syrris has created the unique Atlas Syringe Pump XL...
Brian McNamara named Division Head, Novartis OTC
29 February 2012 | By Novartis
Novartis named Brian McNamara to the position of Division Head of Novartis OTC (Over-the-Counter), effective immediately...
U.S. FDA extends action date for ELIQUIS® (apixaban) by three months
29 February 2012 | By Pfizer
The U.S. FDA has extended the action date by three months for the NDA for Eliquis® (apixaban)...
Abbott and Galapagos announce global collaboration for novel oral therapy, GLPG0634, in Phase II
29 February 2012 | By Abbott
Abbott and Galapagos have entered into a global collaboration...
Two Phase III studies of Novartis drug INC424 published in NEJM show significant clinical benefit for patients with myelofibrosis
29 February 2012 | By Novartis
Results of the COMFORT-I and COMFORT-II trials show INC424 significantly reduced disease burden in patients with myelofibrosis...
